Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Shares Outstanding (2016 - 2025)

vTv Therapeutics (VTVT) has disclosed Shares Outstanding for 11 consecutive years, with $577108.0 as the latest value for Q4 2025.

  • Quarterly Shares Outstanding fell 85.35% to $577108.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $577108.0 through Dec 2025, down 85.35% year-over-year, with the annual reading at $577108.0 for FY2025, 85.35% down from the prior year.
  • Shares Outstanding hit $577108.0 in Q4 2025 for vTv Therapeutics, roughly flat from $577108.0 in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $77.3 million in Q2 2022 to a low of $577108.0 in Q3 2025.
  • Historically, Shares Outstanding has averaged $16.9 million across 5 years, with a median of $2.5 million in 2024.
  • Biggest five-year swings in Shares Outstanding: tumbled 99.25% in 2023 and later skyrocketed 582.2% in 2024.
  • Year by year, Shares Outstanding stood at $1.7 million in 2021, then plummeted by 66.46% to $577349.0 in 2022, then changed by 0.0% to $577349.0 in 2023, then surged by 582.2% to $3.9 million in 2024, then tumbled by 85.35% to $577108.0 in 2025.
  • Business Quant data shows Shares Outstanding for VTVT at $577108.0 in Q4 2025, $3.9 million in Q3 2025, and $2.6 million in Q2 2025.